StockData

BioScience Health Innovations, Inc. (BHIC) stock

BHICOTCServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$6.78+0.00 (0.00%)

Close on Oct 16, 2026Market cap $79.22MP/E –Yield –

BioScience Health Innovations revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

BioScience Health Innovations's revenue for the twelve months ending Jun 30, 2026 was $4.49M, up 7.8% year over year. For fiscal 2025 it was $5.69M, up 208.3% from the year before. The highest annual figure on record is $5.69M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.69M+208.3%
FY2024Dec 31, 2024$1.84M–
FY2022Aug 31, 2022$0–
FY2021Aug 31, 2021$0–
FY2020Aug 31, 2020$0–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$1.04M-41.0%
Q1 FY2026CQ1 2026Mar 31, 2026$750.95K-38.8%
Q4 FY2025CQ4 2025Dec 31, 2025$1.57M+157.7%
Q3 FY2025CQ3 2025Sep 30, 2025$1.13M+97.5%
Q2 FY2025CQ2 2025Jun 30, 2025$1.76M+357.5%
Q1 FY2025CQ1 2025Mar 31, 2025$1.23M+342.0%
Q4 FY2024CQ4 2024Dec 31, 2024$610.22K–
Q3 FY2024CQ3 2024Sep 30, 2024$572.97K–
Q2 FY2024CQ2 2024Jun 30, 2024$384.17K–
Q1 FY2024CQ1 2024Mar 31, 2024$277.60K–
Q4 FY2022CQ3 2022Aug 31, 2022$0–
Q3 FY2022CQ2 2022May 31, 2022$0–
Q2 FY2022CQ1 2022Feb 28, 2022$0–
Q1 FY2022CQ4 2021Nov 30, 2021$0–
Q4 FY2021CQ3 2021Aug 31, 2021$0–
Q3 FY2021CQ2 2021May 31, 2021$0–
Q2 FY2021CQ1 2021Feb 28, 2021$0–
Q1 FY2021CQ4 2020Nov 30, 2020$0–
Q4 FY2020CQ3 2020Aug 31, 2020$0–
Q3 FY2020CQ2 2020May 31, 2020$0–
Q2 FY2020CQ1 2020Feb 29, 2020$0–
Q1 FY2020CQ4 2019Nov 30, 2019$0–

More BioScience Health Innovations figures

See a number that looks wrong?